SOP for IP storage verification – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Thu, 21 Aug 2025 11:21:01 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 SOP for IP Storage, Temperature Control and Excursion Management https://www.clinicalstudies.in/sop-for-ip-storage-temperature-control-and-excursion-management/ Thu, 21 Aug 2025 11:21:01 +0000 ]]> https://www.clinicalstudies.in/sop-for-ip-storage-temperature-control-and-excursion-management/ Read More “SOP for IP Storage, Temperature Control and Excursion Management” »

]]>
SOP for IP Storage, Temperature Control and Excursion Management

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-IP-Storage-Temperature-Control-and-Excursion-Management”
},
“headline”: “SOP for IP Storage, Temperature Control and Excursion Management in Clinical Trials”,
“description”: “This SOP defines procedures for the storage, temperature monitoring, and excursion management of investigational products (IP) in clinical trials, ensuring compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for IP Storage, Temperature Control and Excursion Management

Department Clinical Research
SOP No. CR/IP/032/2025
Supersedes NA
Page No. 1 of 22
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to establish standardized procedures for the storage, temperature monitoring, and excursion management of investigational products (IP) at clinical trial sites. Proper storage safeguards product integrity, ensures participant safety, and maintains compliance with regulatory requirements.

Scope

This SOP applies to all clinical trial staff responsible for handling IP storage, including investigators, pharmacists, study coordinators, and CRO staff. It covers controlled room temperature storage, refrigerated and frozen storage, temperature monitoring, and excursion reporting.

Responsibilities

  • Principal Investigator (PI): Ensures IP is stored in accordance with protocol and regulatory requirements.
  • Pharmacist/Authorized Designee: Maintains IP storage conditions, temperature logs, and manages excursions.
  • Study Coordinator: Files storage and excursion records in ISF and TMF.
  • Sponsor/CRO: Provides guidance on excursion management and reviews storage records during monitoring visits.
  • Quality Assurance Officer: Audits IP storage compliance during inspections.

Accountability

The PI is accountable for ensuring proper storage of IP at all times. Sponsors are accountable for oversight of IP storage practices across all participating sites.

Procedure

1. Storage Requirements
Store IP in secure, access-controlled areas with restricted entry.
Follow manufacturer’s storage requirements (e.g., 2–8°C refrigerated, -20°C frozen, 15–25°C controlled room temperature).
Maintain segregation of different batches and products.

2. Temperature Monitoring
Use calibrated, validated digital thermometers or data loggers.
Record temperatures twice daily (morning and evening) in Temperature Log (Annexure-1).
Retain calibration certificates for equipment.

3. Excursion Management
If temperature falls outside the acceptable range, immediately quarantine affected IP.
Notify PI, sponsor, and QA.
Complete Temperature Excursion Report (Annexure-2).
Await sponsor instructions before releasing product for use.

4. Documentation
Maintain IP Storage Log, Temperature Logs, and Excursion Reports in ISF and TMF.
File corrective actions and sponsor correspondence with storage records.

5. Security and Access
Restrict access to pharmacy or storage area to authorized personnel only.
Maintain access control records.

6. Archiving
Archive all IP storage and excursion records for at least 5 years post-trial or as per national regulations.

Abbreviations

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator
  • IP: Investigational Product
  • CRO: Clinical Research Organization
  • ISF: Investigator Site File
  • TMF: Trial Master File
  • QA: Quality Assurance

Documents

  1. Temperature Monitoring Log (Annexure-1)
  2. Temperature Excursion Report (Annexure-2)
  3. IP Storage Access Log (Annexure-3)

References

Version: 1.0

Approval Section

Prepared By Rajesh Kumar, Clinical Research Pharmacist
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Principal Investigator

Annexures

Annexure-1: Temperature Monitoring Log

Date Time Temperature (°C) Recorded By Remarks
12/09/2025 09:00 4.5°C Ravi Kumar Within range

Annexure-2: Temperature Excursion Report

Date Time Excursion Details Action Taken Reported To
14/09/2025 15:00 Fridge at 10°C for 2 hrs Quarantined IP Sponsor & PI

Annexure-3: IP Storage Access Log

Date Name Role Purpose of Access Signature
15/09/2025 Sunita Sharma QA Officer Audit Signed

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head, Clinical Research

For more SOPs visit: Pharma SOP

]]>
SOP for IP (Investigational Product) Receipt and Verification https://www.clinicalstudies.in/sop-for-ip-investigational-product-receipt-and-verification/ Wed, 20 Aug 2025 21:27:49 +0000 ]]> https://www.clinicalstudies.in/sop-for-ip-investigational-product-receipt-and-verification/ Read More “SOP for IP (Investigational Product) Receipt and Verification” »

]]>
SOP for IP (Investigational Product) Receipt and Verification

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-IP-Receipt-and-Verification”
},
“headline”: “SOP for IP (Investigational Product) Receipt and Verification in Clinical Trials”,
“description”: “This SOP establishes procedures for the receipt and verification of investigational products (IP) in clinical trials, ensuring accountability, compliance, and regulatory adherence under ICH GCP, FDA, EMA, CDSCO, and WHO standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for IP (Investigational Product) Receipt and Verification

Department Clinical Research
SOP No. CR/IP/031/2025
Supersedes NA
Page No. 1 of 22
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to outline standardized procedures for the receipt and verification of investigational products (IP) at clinical trial sites. This ensures that the product is received in good condition, verified against shipping documents, and appropriately recorded for accountability and regulatory compliance.

Scope

This SOP applies to investigators, pharmacists, study coordinators, and other authorized site personnel involved in the receipt, verification, and documentation of investigational products. It covers pharmaceuticals, biologics, medical devices, comparators, and placebos used in clinical trials.

Responsibilities

  • Principal Investigator (PI): Oversees receipt and ensures IP verification is completed as per protocol and regulatory requirements.
  • Pharmacist/Authorized Designee: Performs receipt checks, verifies product details, and documents in IP Receipt Log.
  • Study Coordinator: Ensures shipment documentation is filed in ISF and TMF.
  • Sponsor/CRO: Provides shipping records, monitors compliance, and reviews IP accountability during site visits.
  • Quality Assurance Officer: Reviews IP receipt and verification logs during audits and inspections.

Accountability

The PI is accountable for ensuring that IP receipt and verification activities are performed correctly and documented in compliance with GCP requirements. Sponsors are accountable for oversight and ensuring chain of custody documentation is accurate.

Procedure

1. Preparation for Receipt
Notify PI or pharmacist prior to scheduled shipment.
Ensure designated staff are trained in IP receipt procedures.

2. Receipt of Shipment
Upon arrival, check shipping labels, temperature monitors, and condition of packaging.
Record date and time of receipt in the IP Receipt Log (Annexure-1).

3. Verification of IP
Verify IP details against shipping documents (Annexure-2).
Confirm batch/lot number, expiry date, quantity, and labeling compliance.
Report discrepancies immediately to sponsor/CRO.

4. Documentation
Complete IP Receipt Form signed by responsible staff.
File shipping documents, receipts, and verification forms in ISF and TMF.

5. Temperature Monitoring
Review temperature log data attached with shipment.
Document excursions, if any, and escalate to sponsor for disposition.

6. Archiving
Archive receipt and verification records for at least 5 years post-trial or longer as per regulations.

Abbreviations

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator
  • IP: Investigational Product
  • CRO: Clinical Research Organization
  • ISF: Investigator Site File
  • TMF: Trial Master File
  • QA: Quality Assurance

Documents

  1. IP Receipt Log (Annexure-1)
  2. IP Verification Form (Annexure-2)
  3. Shipment Condition Report (Annexure-3)

References

Version: 1.0

Approval Section

Prepared By Rajesh Kumar, Clinical Research Pharmacist
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Principal Investigator

Annexures

Annexure-1: IP Receipt Log

Date Shipment No. IP Name Batch/Lot No. Quantity Received By
12/09/2025 SHP-101 Investigational Drug X LOT-2025A 200 vials Ravi Kumar

Annexure-2: IP Verification Form

Shipment No. Batch/Lot No. Expiry Date Quantity Verified Discrepancies Verified By
SHP-101 LOT-2025A 30/12/2026 200 vials None Sunita Sharma

Annexure-3: Shipment Condition Report

Shipment No. Packaging Condition Temperature Log Reviewed Remarks
SHP-101 Intact Yes No deviations

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head, Clinical Research

For more SOPs visit: Pharma SOP

]]>